Statin use vs. average non-HDL cholesterol levels in Saint Vincent and the Grenadines
Saint Vincent and the Grenadines: Statin use vs. average non-HDL cholesterol levels was 3.2 in 2018. ▲ Rising
Statin use vs. average non-HDL cholesterol levels in Saint Vincent and the Grenadines, 1980–2018
Source: World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data.
Analysis
The most recent figure for statin use vs. average non-hdl cholesterol levels in Saint Vincent and the Grenadines is 3.2, measured in 2018. That is the highest value across all 39 years on record.
That represents a change of unchanged over ten years.
Over the whole period, statin use vs. average non-hdl cholesterol levels in Saint Vincent and the Grenadines peaked at 3.2 in 2004 and was at its lowest, 3, in 1980.
That places Saint Vincent and the Grenadines 118th out of 191 countries with data for 2018, putting it in the middle of the range.
The long-run direction has been consistently rising across the 39 years of available data.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1980s | 3.06 | 3 | 3.1 | 10 |
| 1990s | 3.1 | 3.1 | 3.1 | 10 |
| 2000s | 3.16 | 3.1 | 3.2 | 10 |
| 2010s | 3.2 | 3.2 | 3.2 | 9 |
Countries ranked near Saint Vincent and the Grenadines
- 118 Armenia 3.2 compare
- 118 Australia 3.2 compare
- 118 Belarus 3.2 compare
- 118 Canada 3.2 compare
- 118 Denmark 3.2 compare
- 118 East Timor 3.2 compare
- 118 India 3.2 compare
- 118 Iran 3.2 compare
- 118 Ireland 3.2 compare
- 118 Kyrgyzstan 3.2 compare
- 118 Moldova 3.2 compare
- 118 Nepal 3.2 compare
- 118 Palau 3.2 compare
- 118 Tanzania 3.2 compare
- 118 Venezuela 3.2 compare
More reference data data for Saint Vincent and the Grenadines
- Emission Totals - Emissions (N2O) - Agricultural Soils 0.0315 (2050)
- Emission Totals - Emissions (CO2eq) from N2O (AR5) - Burning - Crop re 0.0139 (2050)
- Emission Totals - Emissions (CO2eq) from N2O (AR5) - Crop Residues 0.0562 (2050)
- Emission Totals - Emissions (CO2eq) from N2O (AR5) - Manure left on Pa 5.52 (2050)
- Emission Totals - Emissions (CO2eq) from N2O (AR5) - Manure Management 1.79 (2050)
- Emission Totals - Emissions (CO2eq) from N2O (AR5) - Manure applied to 2.77 (2050)
- Emission Totals - Emissions (CO2eq) from N2O (AR5) - IPCC Agriculture 10.15 (2050)
- Emission Totals - Indirect emissions (N2O) - Agricultural Soils 0.0077 (2050)
- Emission Totals - Emissions (N2O) - Manure applied to Soils 0.0105 (2050)
- Emission Totals - Emissions (N2O) - Crop Residues 0.0002 (2050)
Frequently asked questions
- What is statin use vs. average non-hdl cholesterol levels in Saint Vincent and the Grenadines?
- Statin use vs. average non-hdl cholesterol levels in Saint Vincent and the Grenadines was 3.2 in 2018, according to World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data.
- What is the highest statin use vs. average non-hdl cholesterol levels recorded in Saint Vincent and the Grenadines?
- The highest recorded value was 3.2 in 2004.
- What is the lowest statin use vs. average non-hdl cholesterol levels recorded in Saint Vincent and the Grenadines?
- The lowest recorded value was 3 in 1980.
- How does Saint Vincent and the Grenadines rank for statin use vs. average non-hdl cholesterol levels?
- Saint Vincent and the Grenadines ranks 118th out of 191 countries with data for 2018.
- Is statin use vs. average non-hdl cholesterol levels rising or falling in Saint Vincent and the Grenadines?
- Over the last ten years it is unchanged. The long-run trend across the full record is rising.
- Where does this Saint Vincent and the Grenadines data come from?
- The figures come from World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as part of Statin use vs. average non-HDL cholesterol levels. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 39 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.